Form 8-K - Current report:
SEC Accession No. 0001193125-20-279814
Filing Date
2020-10-28
Accepted
2020-10-28 16:10:57
Documents
15
Period of Report
2020-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d57482d8k.htm   iXBRL 8-K 38227
2 EX-4.1 d57482dex41.htm EX-4.1 737902
3 EX-10.1 d57482dex101.htm EX-10.1 1236666
7 GRAPHIC g57482g1028032413514.jpg GRAPHIC 2206
  Complete submission text file 0001193125-20-279814.txt   2583518

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ngvt-20201028.xsd EX-101.SCH 3071
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ngvt-20201028_lab.xml EX-101.LAB 18140
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ngvt-20201028_pre.xml EX-101.PRE 11409
8 EXTRACTED XBRL INSTANCE DOCUMENT d57482d8k_htm.xml XML 3408
Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Filer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37586 | Film No.: 201268755
SIC: 2800 Chemicals & Allied Products